查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1751217

CRO 醫藥分析測試服務市場規模、佔有率、趨勢分析報告：按服務、最終用途、地區、細分市場預測，2025-2030 年

Pharmaceutical Analytical Testing Services In CRO Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Method Development & Validation), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

預計 2024 年 CRO 藥物分析測試服務的全球市場規模將達到 75.2 億美元，2025 年至 2030 年的複合年成長率將達到 8.61%。

這一成長背後的關鍵因素是慢性病患病率的不斷上升、對外包分析測試服務的需求、對藥品研發的投資以及全球向具有成本效益的藥物開發流程的轉變。

製藥公司也擴大將業務外包給合約研究組織 (CRO)，以利用專業知識、最大限度地減少基礎設施的資本投入，並簡化醫藥品認證過程和監管要求的時間。這些測試在整個研發過程中都至關重要，從原料分析和分析方法驗證到穩定性測試和雜質分析。

預計這將推動 CRO 對藥物分析測試服務的需求，以開發個人化和精準藥物，因為 CRO 提供先進的分析技術，如質譜、NGS、拉曼光譜和自動化/AI，以實現快速準確的測試。

此外，生技藥品、生物相似藥和先進療法研發管線的增多，以及為提高藥品安全性、有效性和一致性而加強的品管等因素，也促進了市場的成長。此外，合約研究組織（CRO）擴大採用自動化、人工智慧和數位資料管理系統（例如實驗室資訊管理系統 (LIMS)），預計將使分析測試流程更加高效可靠。這促使製藥公司擴大與CRO的合作，制定成本節約策略並建立策略聯盟，從而推動創新、降低風險並縮短上市時間。

此外，全球嚴格的法律規範也是CRO藥物分析測試服務市場的主要驅動力。美國FDA、EMA、PMDA和WHO等監管機構要求進行全面的分析驗證、分析方法開發和穩定性測試，以提高藥物的安全性、有效性和品質。這些法規變得越來越嚴格，要求進行詳細的特性分析和雜質分析，特別是對於複雜的生技藥品、生物相似藥和先進的治療藥物。 ICH指南（Q2、Q3、Q6）和GMP/GLP標準的實施加劇了對合規分析方法的需求。頻繁的審核和監管檢查進一步影響了製藥公司聘請具有全球監管知識、檢驗的基礎設施和品管系統的專業CRO，從而能夠降低風險、加快核准並保持跨地區的市場進入。

此外，品質源自於設計 (QbD) 原則的採用，強調產品開發的系統化方法，凸顯了早期分析表徵的重要性。在 QbD 框架下，製藥公司必須定義關鍵品質屬性 (CQA)，以確保原料和生產流程的變更不會影響產品效能。美國食品藥物管理局 (FDA) 的流程分析技術 (PAT)舉措正在推動對生產參數的即時監控，以保持產品的一致性。這項監管舉措，加上向更複雜配方的轉變，正在擴大合約研究組織 (CRO) 在藥物分析測試中的作用。預計這些因素將在不久的將來提振整體市場需求。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章 CRO 製藥分析測試服務市場：變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 定價模式分析
  • 技術格局
  • 市場分析工具
    • 波特五力分析
    • PESTEL 與 SWOT 分析
    • COVID-19影響分析

第4章 CRO 製藥分析測試服務市場：按服務分類的估計和趨勢分析

  • CRO 製藥分析測試服務市場（按服務）：細分儀表板
  • CRO 製藥分析測試服務市場（按服務）：變異分析
  • 按服務分類，2018-2030 年
  • 生物分析測試
    • 臨床
    • 非臨床
  • 方法開發和檢驗
    • 可萃取和可浸出
    • 雜質法
    • 技術諮詢
    • 其他
  • 穩定性測試
    • 藥物成分
    • 穩定性指標檢驗
    • 加速穩定性測試
    • 光穩定性測試
    • 其他
  • 其他

第5章 CRO 製藥分析測試服務市場：按最終用途的估計和趨勢分析

  • CRO 醫藥分析測試服務市場（按最終用途）：細分儀表板
  • CRO 製藥分析測試服務市場（依最終用途）：變異分析
  • 依最終用途，2018-2030 年
  • 製藥公司
  • 生物製藥公司
  • 其他

第6章：CRO 製藥分析測試服務市場：按地區估計和趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
    • 波蘭
    • 瑞士
    • 奧地利
    • 捷克共和國
    • 克羅埃西亞
    • 斯洛維尼亞
    • 希臘
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 市場參與企業分類
  • 2024 年公司市場佔有率/估值分析
  • 公司簡介
    • SGS Societe Generale de Surveillance SA
    • Worldwide Clinical Trials
    • Sofpromed
    • ClinChoice
    • Evotec
    • Eurofins Scientific
    • KYMOS Group
    • ViviaBiotech SL
    • GalChimia
    • TCI Laboratories
    • Cotecna（NEOTRON SpA,）
    • Tentamus
    • Enzymlogic
    • Pharmbiotest
    • UNIFARM-Research Centre
    • ANAPHARM EUROPE, SLU
Product Code: GVR-4-68040-576-3

Market Size & Trends:

The global pharmaceutical analytical testing services in CRO market size was estimated at USD 7.52 billion in 2024 and is projected to grow at a CAGR of 8.61% from 2025 to 2030. This growth is primarily attributed to factors such as the growing prevalence of chronic diseases, demand for outsourcing analytical testing services, investments in pharmaceutical R&D, and a shift toward cost-efficient drug development processes across the globe.

In addition, pharmaceuticals are increasingly outsourced to CROs to utilize specialized expertise, minimize their capital investment in the infrastructure, and streamline the timelines for the drug approval process and regulatory requirements. These tests are essential throughout development, from raw materials analysis and method validation to stability studies and impurity profiling.

As CROs offer advanced analytical technologies such as mass spectrometry, NGS, Raman spectroscopy, and automation/AI for rapid and accurate testing are expected to enhance the demand for pharmaceutical analytical testing services in CROs for developing personalized and precision medicine.

Moreover, factors such as an increasing pipeline of biologics, biosimilars, advanced therapies, and rising stringent quality control to enhance pharmaceutical products' safety, efficacy, and consistency are contributing to market growth. Besides, the expanding adoption of automation, artificial intelligence, and digital data management systems like Laboratory Information Management Systems (LIMS) in CROs is anticipated to boost the efficiency and reliability of analytical testing processes. This led pharmaceutical companies to expand their partnerships with CROs for cost-saving strategies and strategic collaborations that boost innovation, reduce risk, and improve time-to-market.

Furthermore, stringent regulatory frameworks worldwide are another major driver for the pharmaceutical analytical testing services in CRO market. Regulatory authorities such as the U.S. FDA, EMA, PMDA, and WHO require comprehensive analytical validation, method development, and stability testing to enhance drug safety, efficacy, and quality. These regulations are becoming increasingly stringent, particularly for complex biologics, biosimilars, and advanced therapies, mandating in-depth characterization and impurity profiling. The implementation of ICH guidelines (Q2, Q3, Q6) and GMP/GLP standards has intensified the demand for compliant analytical methodologies. Frequent audits and regulatory inspections further influence pharmaceutical companies to engage with specialized CROs possessing global regulatory knowledge, validated infrastructure, and quality management systems, allowing risk mitigation, faster approvals, and sustained market access across geographies.

Further, the adoption of Quality by Design (QbD) principles, which emphasize a systematic approach to product development, highlights the importance of early-stage analytical characterization. Under the QbD framework, pharmaceutical companies must define Critical Quality Attributes (CQAs) and ensure that variations in raw materials or manufacturing processes do not compromise product performance. The FDA's Process Analytical Technology (PAT) initiative promotes real-time monitoring of manufacturing parameters to maintain product consistency. This regulatory push, combined with the industry's transition toward more sophisticated drug formulations, is expanding the role of CROs in pharmaceutical analytical testing. Such aforementioned factors are expected to drive the overall market demand in the near future.

Global Pharmaceutical Analytical Testing Services In CRO Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pharmaceutical analytical testing services in CRO market report based on service, end use and region.

  • Service Outlook (Revenue, USD Million, 2018 - 2030)
  • Bioanalytical Testing
    • Clinical
    • Non-Clinical
  • Method Development & Validation
    • Extractable & Leachable
    • Impurity Method
    • Technical Consulting
    • Others
  • Stability Testing
    • Drug Substance
    • Stability Indicating Method Validation
    • Accelerated Stability Testing
    • Photostability Testing
    • Others
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
    • Poland
    • Switzerland
    • Austria
    • Czech Republic
    • Croatia
    • Slovenia
    • Greece
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Argentina
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Analytical Testing Services in CRO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Pricing Model Analysis
  • 3.4. Technology Landscape
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's Five Force Analysis
    • 3.5.2. PESTEL by SWOT Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Analytical Testing Services in CRO Market: Service Estimates & Trend Analysis

  • 4.1. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Segment Dashboard
  • 4.2. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Movement Analysis
  • 4.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
  • 4.4. Bioanalytical Testing
    • 4.4.1. Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Clinical
      • 4.4.2.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Non-Clinical
      • 4.4.3.1. Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Method Development & Validation
    • 4.5.1. Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Extractable & Leachable
      • 4.5.2.1. Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Impurity Method
      • 4.5.3.1. Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Technical Consulting
      • 4.5.4.1. Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Stability Testing
    • 4.6.1. Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Drug Substance
      • 4.6.2.1. Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Stability Indicating Method Validation
      • 4.6.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Accelerated Stability Testing
      • 4.6.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Photostability Testing
      • 4.6.5.1. Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. Others
      • 4.6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Analytical Testing Services in CRO Market: End Use Estimates & Trend Analysis

  • 5.1. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Segment Dashboard
  • 5.2. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Movement Analysis
  • 5.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 5.4. Pharmaceutical Companies
    • 5.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Biopharmaceutical Companies
    • 5.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Analytical Testing Services in CRO Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. North America
    • 6.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.S
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Framework
      • 6.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.10. Poland
      • 6.4.10.1. Key Country Dynamics
      • 6.4.10.2. Competitive Scenario
      • 6.4.10.3. Regulatory Framework
      • 6.4.10.4. Poland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.11. Switzerland
      • 6.4.11.1. Key Country Dynamics
      • 6.4.11.2. Competitive Scenario
      • 6.4.11.3. Regulatory Framework
      • 6.4.11.4. Switzerland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.12. Austria
      • 6.4.12.1. Key Country Dynamics
      • 6.4.12.2. Competitive Scenario
      • 6.4.12.3. Regulatory Framework
      • 6.4.12.4. Austria Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.13. Czech Republic
      • 6.4.13.1. Key Country Dynamics
      • 6.4.13.2. Competitive Scenario
      • 6.4.13.3. Regulatory Framework
      • 6.4.13.4. Czech Republic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.14. Croatia
      • 6.4.14.1. Key Country Dynamics
      • 6.4.14.2. Competitive Scenario
      • 6.4.14.3. Regulatory Framework
      • 6.4.14.4. Croatia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.15. Slovenia
      • 6.4.15.1. Key Country Dynamics
      • 6.4.15.2. Competitive Scenario
      • 6.4.15.3. Regulatory Framework
      • 6.4.15.4. Slovenia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.16. Greece
      • 6.4.16.1. Key Country Dynamics
      • 6.4.16.2. Competitive Scenario
      • 6.4.16.3. Regulatory Framework
      • 6.4.16.4. Greece Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Australia
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Company Market Share/Assessment Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. SGS Societe Generale de Surveillance SA
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Service Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Worldwide Clinical Trials
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Service Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Sofpromed
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Service Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. ClinChoice
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Service Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Evotec
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Service Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Eurofins Scientific
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Service Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. KYMOS Group
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Service Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. ViviaBiotech S.L.
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Service Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. GalChimia
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Service Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. TCI Laboratories
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Service Benchmarking
      • 7.3.10.4. Strategic Initiatives
    • 7.3.11. Cotecna (NEOTRON SpA,)
      • 7.3.11.1. Company Overview
      • 7.3.11.2. Financial Performance
      • 7.3.11.3. Service Benchmarking
      • 7.3.11.4. Strategic Initiatives
    • 7.3.12. Tentamus
      • 7.3.12.1. Company Overview
      • 7.3.12.2. Financial Performance
      • 7.3.12.3. Service Benchmarking
      • 7.3.12.4. Strategic Initiatives
    • 7.3.13. Enzymlogic
      • 7.3.13.1. Company Overview
      • 7.3.13.2. Financial Performance
      • 7.3.13.3. Service Benchmarking
      • 7.3.13.4. Strategic Initiatives
    • 7.3.14. Pharmbiotest
      • 7.3.14.1. Company Overview
      • 7.3.14.2. Financial Performance
      • 7.3.14.3. Service Benchmarking
      • 7.3.14.4. Strategic Initiatives
    • 7.3.15. UNIFARM - Research Centre
      • 7.3.15.1. Company Overview
      • 7.3.15.2. Financial Performance
      • 7.3.15.3. Service Benchmarking
      • 7.3.15.4. Strategic Initiatives
    • 7.3.16. ANAPHARM EUROPE, S.L.U
      • 7.3.16.1. Company Overview
      • 7.3.16.2. Financial Performance
      • 7.3.16.3. Service Benchmarking
      • 7.3.16.4. Strategic Initiatives

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 5 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 9 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 11 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 13 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 15 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 18 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 19 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 20 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 22 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 23 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 24 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 26 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 28 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 29 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 30 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 32 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 34 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 35 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 36 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 38 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 40 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 41 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 42 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 43 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 44 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 46 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 47 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 48 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 53 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 54 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 55 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 56 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 57 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 59 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 60 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 61 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 63 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 65 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 66 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 68 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 70 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 72 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 74 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 75 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 76 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 77 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 78 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 79 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 81 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Pharmaceutical Analytical Testing Services in CRO Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Pharmaceutical Analytical Testing Services in CRO Market: Service outlook and key takeaways
  • Fig. 20 Pharmaceutical Analytical Testing Services in CRO Market: Service movement analysis
  • Fig. 21 Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others Service Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Pharmaceutical Analytical Testing Services in CRO Market: End Use outlook and key takeaways
  • Fig. 37 Pharmaceutical Analytical Testing Services in CRO Market: End Use movement analysis
  • Fig. 38 Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Regional Marketplace: Key Takeaways
  • Fig. 42 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key Country Dynamics
  • Fig. 44 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key Country Dynamics
  • Fig. 46 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key Country Dynamics
  • Fig. 51 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key Country Dynamics
  • Fig. 53 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key Country Dynamics
  • Fig. 55 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key Country Dynamics
  • Fig. 57 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key Country Dynamics
  • Fig. 59 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key Country Dynamics
  • Fig. 61 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key Country Dynamics
  • Fig. 63 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key Country Dynamics
  • Fig. 77 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key Country Dynamics
  • Fig. 79 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key Country Dynamics
  • Fig. 82 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key Country Dynamics
  • Fig. 84 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key Country Dynamics
  • Fig. 86 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key Country Dynamics
  • Fig. 88 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key Country Dynamics
  • Fig. 90 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key Country Dynamics
  • Fig. 92 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key Country Dynamics
  • Fig. 95 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key Country Dynamics
  • Fig. 97 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 MEA Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key Country Dynamics
  • Fig. 100 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key Country Dynamics
  • Fig. 102 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key Country Dynamics
  • Fig. 104 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key Country Dynamics
  • Fig. 106 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key company categorization
  • Fig. 108 Service heat map analysis
  • Fig. 109 Strategic framework